Malignant tumor of biliary tract (disorder)
ABC-03 -
Year Started: 2011
Randomised phase II trial of cediranib (AZD2171) vs. placebo in addition to cisplatin / gemcitabine chemotherapy for patients with advanced biliary tract cancers
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
Other animal work restriction, Outside EU access restriction, Xenograft restriction
Associated Data Type |
Procurement Timeframe |
Biomarker datasets |
0 - 3 months |
Clinical records |
0 - 3 months |
Followup records |
0 - 3 months |
Imaging data |
0 - 3 months |
Pathology records |
0 - 3 months |
Quality indicators |
0 - 3 months |
Treatment records |
0 - 3 months |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Not applicable |
0 - 10% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Not applicable |
0 - 10% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |